Martin Capital Advisors’s SELLAS Life Sciences SLS Stock Holding History

Martin Capital Advisors’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341K	Buy	+23,082	New	+$159K	0.18%	69

Other funds holding SLS

DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Fulcrum Wealth Advisors Bellevue, Washington $131M AUM

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return

Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return

Financial Designs Claremont, California $187M AUM 14.59% 1-Year Est. Return

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Martin Capital Advisors's SLS Position: Q2 2026 in Review

Martin Capital Advisors opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 23,082 shares worth $341K. The stake represents 0.18% of the portfolio and ranks #69 among its holdings.

29 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

Martin Capital Advisors held 23,082 shares of SELLAS Life Sciences worth $341K as of Q2 2026.
SELLAS Life Sciences was a new Martin Capital Advisors position in Q2 2026.
SELLAS Life Sciences made up 0.18% of Martin Capital Advisors's portfolio in Q2 2026, its #69 holding.
29 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Martin Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.